Anti Aging Market

Anti Aging Market: Industry Trends and Global Forecasts, till 2040 - Distribution by Type of Molecule (Biologics and Small Molecules), Type of Aging (Cellular Aging, Immune Aging, Metabolic Aging and Others) and Key Geographies (North America, Europe, Asia Pacific, and Rest of the World)

  • Lowest Price Guaranteed From USD 4,799

  • Companies Covered
    137

  • Slides
    249

  • View Count
    10769

Anti Aging Market Size Overview

The anti aging market is estimated to grow from $79 million in 2025 to $2.8 billion in 2040, growing at a CAGR of 27% during the forecast period 2025 - 2040. The new research study consists of industry trends, detailed market analysis, key market insights, market impact analysis, and anti-aging market forecast and opportunity analysis.

Anti Aging Market Size, By Type of Molecule, 2025-2040 (USD Billion)

To learn more about this report, request a free sample copy

The advancements in healthcare and available technologies have inadvertently led to an increase in the life expectancy of individuals. However, this has also led to a rise in the aging population worldwide. According to the United Nations, the aforementioned trend is one of the key transformations observed in the 21st century; it is expected to have an impact on all sections of society. Aging is linked to a variety of diseases, including cardiovascular disorders, neurodegenerative disorders, oncological disorders and musculoskeletal disorders, which further puts heavy economic and psychological burden on the patients, their families and the society.

As per the World Health Organization, in 2020, close to 1 billion people were estimated to be aged 65 or above, globally. In addition, the share of elderly population is expected to increase from 9.3% in 2020 to 16% in 2050. Aging biology is still a largely unexplored field, in terms of the development of safe and effective novel pharmacotherapies. Anti-aging drug, therefore, is an emerging field of medical science focused on reducing or reversing the underlying causes of aging through different mechanisms, in order to extend healthy lifespan of humans. Driven by the growing aging population, ongoing pace of innovation in this field and financial support from investors, the anti-ageing market is anticipated to witness substantial market growth during the forecast period.

Anti-Aging Market Scope

The market research report presents an in-depth analysis of the various companies that are engaged in the development of anti aging drug / therapies, across different segments, as defined in the table below:

Global Anti Aging Market: Report Attributes / Market Segmentations

Key Report Attribute Details
Historical Trend 2018-2023
Base Year 2023
Forecast Period 2025-2040
Market Size 2025 $79 Million
CAGR 27%
Type of Molecule
  • Biologics
  • Small Molecules
Type of Aging
  • Cellular Aging
  • Immune Aging
  • Metabolic Aging
  • Others
Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific and Rest of the World
Key Companies Profiled
  • AgelessRx
  • ANOVA Institute for Regenerative Medicine
  • Betterhumans
  • BioAge Labs
  • bioXcellerator
  • Cambrian Biopharma
  • Gero.ai, Mayo Clinic
  • Rejuvenate Bio
  • UT Health San Antonio
(Full list of 135+ companies captured is available in the report)
PowerPoint Presentation
(Complimentary)
Available
Customization 15% Free Customization
Excel Data Packs (Complimentary) 
  • Market Landscape Analysis
  • Company Competitiveness Analysis
  • Partnerships and Collaborations
  • Funding and Investments
  • Patent Analysis
  • Publication Analysis
  • Porter’s Five Forces Analysis
  • Market Forecast and Opportunity Analysis


One of the key objectives of this anti-aging market report was to estimate the current market size, opportunity and the future market growth potential of this domain in pharmaceutical market, over the forecast period. We have provided an informed estimate on the market evolution during the forecast period 2023-2040. The market report also features the likely distribution of the current and forecasted opportunity within the anti-aging market across various segments, such as type of molecule (biologics and small molecules), type of aging (cellular aging, immune aging, metabolic aging and others) and key geographies (North America, Europe, Asia Pacific, and Rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the anti-aging market growth.

The opinions and insights presented in the market research report were also influenced by discussions held with multiple stakeholders in anti-aging market. The market report features detailed transcripts of interviews held with the following individuals:

  • Co-Founder and Chief Executive Officer, Small Company, Singapore
  • President, Small Company, US
  • Chief Operating Officer, Small Company, Singapore
  • Senior Director of Global Corporate Communications, Small Company, US
  • Director and Consultant Obstetrician and Gynaecologist, Small Company, Malaysia

All actual figures have been sourced and analysed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Anti Aging Market: Key Insights

The “Anti-Aging Market: Industry Trends and Global Forecasts, till 2040 - Distribution by Type of Molecule (Biologics and Small Molecules), Type of Aging (Cellular Aging, Immune Aging, Metabolic Aging and Others) and Key Geographies (North America, Europe, Asia Pacific, and Rest of the World)” market report features an extensive study of the current market landscape, market size, market share, market analysis, market forecast and future opportunities for the anti-aging companies involved in the pharmaceutical market. The report highlights the efforts of several drug developers engaged in this rapidly emerging market segment of the pharmaceutical industry. Key takeaways of the anti-aging market analysis are briefly discussed below.

Awareness Amongst the Consumers is Driving the Demand for Anti-Aging Drugs

Given the rapidly growing aging population, the ongoing efforts to discover anti aging drug candidates that enhance the lifespan of an individual by targeting the pathogenesis of aging have become a popular topic for research. At present, various anti aging products and devices, including direct-to-consumer nutraceuticals, plastic surgeries, cosmetics, skincare products, senolytics and devices, are available in the market to slow the process of aging.

Anti-Aging Market Trends: Increase in Patent Publications and Funding Reflects the Rising Interest in Anti-Aging Market

Over 660 patents related to anti-aging drug and anti-ageing therapeutics have been recently filed / granted, demonstrating the continued innovation in this domain.

Several start-ups and academic / research institutes across the world are evaluating various types of anti aging drug products, including stem cell therapies, metformin, rapamycin, resveratrol and senolytics (drugs that selectively clear senescent cells), in multiple preclinical / clinical studies. Owing to the encouraging results demonstrating the ability of novel anti aging drug candidates in delaying the aging process, capital investments worth USD 4 billion have been made by various private and public sector investors in the last five years to fund product development initiatives. In August 2022, clock.bio launched out of stealth with $4 million funding. The company aims to harness the regenerative capabilities of human pluripotent stem cells to extend and improve quality of life by reversing the harmful effects of time in human cells.

Regional Analysis: North America to Hold the Largest Share in Anti-Aging Market

North America emerged as the hub for therapeutic developers engaged in the anti-aging market, with close to 70% of the companies established in the region. Consequently, majority of the global market for anti aging drugs is anticipated to be captured by companies based in North America, in 2040.

However, several developments are taking place in other regions as well, promoting the development of anti-aging therapeutics. In 2021, a non-profit organization, the Hevolution Foundation was set up in Saudi Arabia to provide grants to companies working in the field of healthspan sciences. The foundation organized a two-day summit on ‘Global Healthspan Summit, held at Riyadh, Saudi Arabia in November 2023. In January 2024, Genflow Biosciences, a drug developer actively working in the field of longevity, secured research grants from the Government of Wallonia in Belgium to initiate two new research programs in collaboration with Revatis and EXO Biologics.

Key Anti Aging Companies Developing Therapeutics in Anti Aging Market

Examples of key anti-aging (which have also been profiled in this market report; the complete list of anti-aging companies is available in the full report) include AgelessRx, ANOVA Institute for Regenerative Medicine, Betterhumans, BioAge Labs, bioXcellerator, Cambrian Biopharma, Gero.ai, Mayo Clinic, Rejuvenate Bio and UT Health San Antonio. This market report includes an easily searchable excel database of all the anti-aging companies, worldwide.

Anti-Aging Market Report Coverage

The anti-aging market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different geographies. Amongst other elements, the market research report includes:

  • A preface providing an introduction to the full report, Anti Aging Market: Industry Trends and Global Forecasts, till 2040.
The image provides context of anti-aging therapeutics market. Anti-aging therapeutics have emerged as a promising alternative to conventional treatments, such as cosmetics, surgeries and supplements; once approved, these therapies are likely to capture a significant market share This image provides list of anti-aging therapeutics. Presently, more than 65 anti-aging therapeutics are being developed worldwide; majority of the developers are small firms based in North America The image provides details on the anti-aging therapeutics market landscape. These therapeutics, ranging from a variety of biologics and small molecules, are currently being investigated across different phases of development

 

  • An outline of the systematic research methodology adopted to conduct the study on anti-aging drugs / therapies providing insights on the various assumptions, methodologies, and quality control measures employed to ensure accuracy and reliability of our findings.
  • An executive summary of the key insights captured during our research, offering a high-level view on the current landscape of the anti aging market and their likely evolution in the short to mid and long term.
  • A detailed assessment of the current market landscape of anti aging drug and anti aging therapeutics, featuring information on phase of development (commercial, phase II, phase I / II, phase I, clinical (phase unknown), discovery / preclinical and undisclosed), type of aging (cellular aging, metabolic aging, immune aging, others and undisclosed), type of molecule (biologics and small molecules), mechanism of action (senolytic, cell regeneration, mammalian target of rapamycin (mTOR) inhibitor / modulator, adenosine monophosphate (AMP)-kinase / AMP activator, mitochondria inhibitor / modulator and others) and type of developer (industry and non-industry). In addition, the chapter features analyses of anti-aging therapeutic developers based on parameters, such as year of establishment, company size, location of headquarters and leading developers (in terms of number of pipeline candidates).
  • A competitiveness analysis of anti-aging therapeutic developers, based on various relevant parameters, namely supplier power (based on the experience of the developer) and company competitiveness (based on highest phase of development, type of aging and type of molecule).
  • An analysis of partnerships that have been inked by stakeholders engaged in anti-ageing market, during the period 2018-2022. Further, the partnership activity in this domain has been analyzed based on various parameters, such as year of partnership, type of partnership, most active players (in terms of number of partnerships), type of partner and regional distribution of collaborations.
  • A detailed analysis of investments that have been made into companies which are developing proprietary anti-ageing drug and anti-aging therapeutics, during period 2018-2022. The various types of funding instances reported in anti-aging market include pre-seed financing, seed financing, venture capital financing, capital raised from IPOs and subsequent public offerings, grants, crowdfunding, and donations.
The image looks at the competitive landscape across Anti-aging Therapeutics Developers. Firms are actively upgrading their existing capabilities to further enhance their respective product pipeline and comply to the evolving industry benchmarks This infographic looks at the various partnership deals inked by stakeholders in Anti-aging Therapeutics domain. The rising interest is evident from the rise in partnership activity related to research of regenerative medicine; the maximum number of such deals were signed in North America This infographic looks at the funding raised by players in Anti-aging Therapeutics domain. Foreseeing the lucrative potential associated with anti-aging therapies, a large number of investors have made investments worth around USD 4 billion across multiple funding rounds

 

  • An in-depth analysis of the various patents that have been filed / granted related to anti-aging drug and anti-aging therapeutics, during 2018-2022, taking into consideration parameters, such as publication year, type of patent, geographical region, CPC symbols, key focus areas, type of applicant, patent age and leading players (in terms of size of intellectual property portfolio). It also features a patent benchmarking analysis and a detailed valuation analysis.
  • A detailed review of more than 220 peer-reviewed, scientific articles related to research on anti-aging drug and anti-ageing therapeutics, during the period 2018-2022, based on several relevant parameters, such as year of publication, type of publication, popular keywords and geography of affiliations. The chapter also provides information on the most popular publisher, most popular journal, most popular affiliations and most popular funding institutes (in terms of number of articles published).
  • A qualitative analysis, highlighting the five competitive forces prevalent in anti-aging market, including threats for new entrants, bargaining power of suppliers, bargaining power of buyers, threats of substitute products and rivalry among existing competitors.
  • Elaborate profiles of prominent players engaged in the development of anti-aging drug and anti-aging therapeutics, featuring a brief overview of the company, details related to its product portfolio, recent developments and an informed future outlook.
  • A detailed anti-aging market statistics including the existing market size and future opportunity for anti-aging therapeutics, during the forecast period 2022-2040. The anti-ageing market research report also includes likely sales forecasts of anti aging therapeutics that are in the mid to late stages of development. Additionally, it features market size projections for the overall anti-ageing market, wherein both the current and upcoming opportunity is segmented across type of molecule (biologics and small molecules), type of aging (cellular aging, immune aging, metabolic aging and others) and key geographies (North America, Europe, Asia Pacific, and Rest of the world).
This image looks at the details of patents related to Anti-aging Therapeutics. Over 660 patents related to anti-aging therapeutics have recently been filed / granted, indicating the growing intellectual capital in this domain This image looks at the five forces impacting players involved in the anti-aging therapeutics domain. Increasing clinical research and funding activity in the anti-aging domain is anticipated to create profitable business opportunities for the anti-aging therapeutic developers This image provides details on anti-aging therapeutics market size. The market is expected to grow at an annualized rate of over 15%; the overall opportunity is anticipated to be well distributed across different types of molecules, types of aging and key geographical regions

 

Recent Developments In Anti-Aging Market

Several recent developments have taken place related to anti-aging industry, some of which have been outlined below.

  • In February 2024, Rejuvenate Bio demonstrated through a research study that gene therapy-mediated partial reprogramming could extend overall lifespan in normal, aged mice.
  • In July 2023, researchers from the Harvard Medical School identified the first chemically induced cellular aging reversal using six novel chemical compounds that have the potential to restore the youthful state of cells within a week.
  • In January 2023, a research study conducted by the University of Bristol and the MultiMedica Group in Italy identified a novel anti-aging gene, having the potential to restore the age of heart cells by 10 years.

Frequently Asked Questions

Question 1: What are anti-aging therapies?

Answer: Anti-aging therapies are an emerging field of medical science focused on reducing or reversing the underlying causes of aging through different mechanisms, in order to extend healthy lifespan of humans.

Question 2: How big is the anti-ageing market?

Answer: The anti-aging market size for therapeutics is estimated to be worth $79 million by 2025.

Question 3: What is the projected anti-aging market growth?

Answer: The global anti-aging market is expected to grow at compounded annual growth rate (CAGR) of over 27% during the forecast period 2025 - 2040.

Question 4: Who are the leading anti-aging companies developing therapeutics in the anti-aging market?

Answer: Examples of key anti-aging companies include AgelessRx, ANOVA Institute for Regenerative Medicine, Betterhumans, BioAge Labs, bioXcellerator, Cambrian Biopharma, Gero.ai, Mayo Clinic, Rejuvenate Bio and UT Health San Antonio.

Question 5: How many patents related to anti-aging therapies have been filed / granted over the last few years?

Answer: Since 2018, more than 660 patents related to anti-ageing therapies have been filed / granted.

Question 6: How much money has been invested by stakeholders in the companies’ developing anti-aging therapeutics?

Answer: The anti aging market analysis shows that over USD 3.5 billion has been invested in companies developing anti aging therapeutics since 2018, highlighting the rising interest of stakeholders in the industry.

Question 7: Which region is the hub for therapeutic developers engaged in the anti-ageing market?

Answer: North America emerged as the hub for therapeutic developers engaged in the anti-aging market, with close to 70% of the companies established in the region.

PRICING DETAILS

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer Read more about Department License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com